FDA will fill more than 1300 positions within the next several months.
Rockville, MD-April 30, 2008-Biologists, chemists, medical officers, mathematical statisticians and investigators are among the experts in demand as the U.S. Food and Drug Administration begins a multi-year hiring initiative.
The FDA is hiring hundreds of individuals with science and medical backgrounds to help meet the agency’s responsibilities to assure the safety and/or efficacy of human and veterinary drugs, biological products, medical devices, food, cosmetics, and products that emit radiation.
“It takes a large pool of talented people for the FDA to protect and promote the public health,” said John Dyer, FDA’s deputy commissioner for operations and chief operating officer. “Each month there is a delay in bringing critical staff on board impairs the agency’s ability to fulfill this mission.”
In fiscal year 2008 alone, the FDA is looking to fill more than 600 new positions and to backfill over 700 others to implement the FDA Amendments Act of 2007, the Food Protection Plan and the Import Safety Action Plan. That’s nearly triple the number of people hired from 2005–2007.
The Office of Personnel Management has granted Direct-Hire Authority to the FDA, an operating division of the Department of Health and Human Services. OPM’s actions reflect the Administration’s commitment to strengthening the agency quickly.
Direct-Hire Authority is an appointing authority OPM can give to federal agencies for filling vacancies when a critical hiring need or severe shortage of candidates exists. It expedites hiring of qualified candidates by eliminating certain rating and ranking preferences. Qualified candidates could be on the job in as little as three weeks.
The critical need occupations are medical officers, consumer safety officers, chemists, nurse consultants, biologists, microbiologists, health/regulatory/general health scientists, mathematical statisticians, epidemiologists, pharmacologists, pharmacists, and veterinary medical officers. Many of these positions are located in the Washington metropolitan area, specifically Rockville; Silver Spring; and College Park, MD, as well as across the country in the FDA’s five regions, 20 districts, more than 179 resident posts, and the newly created FDA offices overseas.
Positions will be available throughout the agency, including in the Center for Biologics Evaluation and Research, the Center for Drug Evaluation and Research, the Center for Devices and Radiological Health, the Center for Food Safety and Nutrition, the Center for Veterinary Medicine, the National Center for Toxicological Research, the Office of the Commissioner, and the Office of Regulatory Affairs.
The FDA will be participating in and holding job fairs throughout the country. To find a job fair near you, visit www.fda.gov/jobs. For general information and to apply for one of the positions listed above, submit your questions and electronic curriculum vitae with a cover letter via email at JOINOURTEAM@FDA.gov.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.